Back to FDA Applications sponsored by NAPO PHARMS INC

FDA Drug Application 202292 by NAPO PHARMS INC

Application Number202292
Application Type New Drug Application
Sponsor ApplicantNAPO PHARMS INC
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New molecular entity (NME)
Therapeutic Potential Priority
Orphan Code 


  
Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP012/31/2012N34805000   http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202292s000lbl.pdf 12/31/2012
AP012/31/2012N34808000   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/202292Orig1s000ltr.pdf 1/2/2013
AP012/31/2012N35185000   http://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/202292Orig1s000TOC.cfm 2/19/2013
AP012/31/2012N35186000   http://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/202292Orig1s000SumR.pdf 2/19/2013
AP011/6/2013SCM       
AP08/20/2014SCM       




Back to FDA Applications sponsored by NAPO PHARMS INC